Phytochemical, Admet and Docking  Studies on Valeriana Officinalis for  Predicting Antiepilpetic Drug Molecules

R. Caroline Nirmala; V. K. Gopalakrishnan

Volume : II, Issue : VII, July - 2013

Phytochemical, Admet and Docking Studies on Valeriana Officinalis for Predicting Antiepilpetic Drug Molecules

R. Caroline Nirmala, V. K. Gopalakrishnan

Abstract :

Epilepsy is a second common neurological disorders characterized by repeated seizures. This is a genetic disorder caused by mutation in Laforin, encoded by the EPM2Agene. Laforin is a protein mutated in patients with Lafora disease. EPM2A codes for the protein laforin, a dual-specificity phosphatase with a carbohydrate binding domain (CBM-20). In order to inhibit the dual specificity action of laforin protein we perform docking analysis by using phytochemicals from the medicinal plant Valeriana officinalis. For this the phytochemicals of the plant valariana has been retrieved from plant databases and its ADMET properties have been studied. The phytochemical compounds satisfying ADMET properties were selected for docking analysis. To carry out docking analysis the target Laforin has been retrieved from Protein modeling database. The active site has been predicted for this model and analysed. Molecular docking studies have been performed for this model. The phytochemical compounds with good docking score and binding affinity was investigated from this study.